Received: 5 September 2019
Accepted: 15 October 2019
First Online: 25 October 2019
Ethics approval and consent to participate
: This study was approved by Mazandaran University of Medical Sciences ethics committee All performed on the enlarged ethical statementIR.MAZUMS.REC.1397.3045 meeting number. In this study, all ethics including Ethics and Consent to participate in biofilm-forming <i>S. aureus</i> wild type strain has been collected. <i>S. epidermidis</i> strains were gifted from the Laboratory of Medical Microbiology, Department of Medical Diagnostic Sciences, KU Leuven, U.Z. Gasthuisberg, Herestraat 49 CDG 8th floor, 3000, Leuven, Belgium. Biofilm forming <i>S. aureus</i> as wild type strain was prepared from a clinical Specimen based on the previous accomplished study (Determining the Biofilm Forming Gene Profile of <i>Staphylococcus aureus</i> Clinical Isolates via Multiplex Colony PCR Method) under Ethics committee. Verbal informed consent from all participants had been gathered at the mentioned study. Bacterial strains: Two PIA+ and PIA− <i>S. epidermidis</i> strains (ATCC 14990 also named 1457 and 1457- M10) were gifted from Belgium and a biofilm-forming <i>S. aureus</i> wild type was used for PIA and Gly-TA purification and related procedures.
: Not applicable.
: The authors declare that they have no competing interests.